# A Safety Study of LY2886721 Multiple Doses in Healthy Subjects

> **NCT01227252** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 42 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** LY2886721
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01227252
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2019-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01227252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01227252, "A Safety Study of LY2886721 Multiple Doses in Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01227252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*